Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 2 Genitourinary 1

Conditions

Prostatic Neoplasms 4 Urinary Bladder Neoplasms 2 Kidney Neoplasms 2 Uterine Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Diseases 1 Pelvic Organ Prolapse 1 Pancreatic Neoplasms 1 Obesity, Morbid 1 Neoplasms 1 Mediastinal Neoplasms 1 Lung Neoplasms 1 Hernia, Ventral 1 Hernia, Inguinal 1 Head and Neck Neoplasms 1 Genital Diseases, Female 1 Esophageal Neoplasms 1

Interventions

pembrolizumab 28 Docetaxel 21 Gemcitabine 19 Nivolumab 15 Paclitaxel 13 Prednisone 12 Leuprolide 11 pazopanib 10 Radiotherapy 10 Cisplatin 10 Sunitinib 9 Sorafenib 9 Ipilimumab 8 Blood Specimen Collection 8 Bevacizumab 8 avelumab 7 atezolizumab 7 Therapeutics 7 Thalidomide 7 Cyclophosphamide 7 Carboplatin 7 Standard of Care 6 Radiation 6 Mitomycin 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 padeliporfin 5 enzalutamide 5 cemiplimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Robotic Surgical Procedures × Genitourinary × Clear all

NCT03011606 2020-01-27

RAFT

Queen Mary University of London

Phase NA Completed

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡